ISIS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Fees and other income is the income earned by insurance companies other than providing insurances. Isis Pharmaceuticals's fees and other income for the three months ended in Jun. 2014 was $57.1 Mil. Its fees and other income for the trailing twelve months (TTM) ended in Jun. 2014 was $151.1 Mil.
Isis Pharmaceuticals's quarterly fees and other income declined from Dec. 2013 ($42.2 Mil) to Mar. 2014 ($28.2 Mil) but then increased from Mar. 2014 ($28.2 Mil) to Jun. 2014 ($57.1 Mil).
Isis Pharmaceuticals's annual fees and other income increased from Dec. 2011 ($99.1 Mil) to Dec. 2012 ($102.0 Mil) and increased from Dec. 2012 ($102.0 Mil) to Dec. 2013 ($147.3 Mil).
Income earned by insurance companies other than providing insurances. It includes investing income, fees and interest income.
Isis Pharmaceuticals Fees and Other Income for the trailing twelve months (TTM) ended in Jun. 2014 was 23.585 (Sep. 2013 ) + 42.249 (Dec. 2013 ) + 28.161 (Mar. 2014 ) + 57.076 (Jun. 2014 ) = $151.1 Mil.
Isis Pharmaceuticals Annual Data
Isis Pharmaceuticals Quarterly Data